Publications by authors named "David Reisman"

Claim this Profile
R
Reply.
Kayla Berigan, Ryan Short, David Reisman, Laura McCray, Joan Skelly

J Am Coll Radiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Large Language Model-Generated Radiology Report Summaries on Patient Comprehension: A Randomized Controlled Trial.
Kayla Berigan, Ryan Short, David Reisman, Laura McCray, Joan Skelly

J Am Coll Radiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telemedicine Use in Disasters: A Scoping Review.
Mark Litvak, Katherine Miller, Tehnaz Boyle, Rachel Bedenbaugh, Christina Smith, David Reisman

Disaster Med Public Health Prep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Context is key: Understanding the regulation, functional control, and activities of the p53 tumour suppressor.
Anne H Moxley, David Reisman

Cell Biochem Funct· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Design and Implementation of a Professional Development Program for Physician Assistants in an Academic Emergency Department.
Derek L Monette, Brian Baccari, Laura Paskind, David Reisman, Elizabeth S Temin

AEM Educ Train· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
Min Joon Lee, Nathan Kuehne, Katrina Hueniken, Shermi Liang, Sudhir Rai, David Reisman

Mol Carcinog· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Emergency Preparedness Resources and Capabilities Among Academic Health Systems in the United States.
Paul D Biddinger, David Reisman, Robert F Seger, Ann L Prestipino, Julia Sinclair

Disaster Med Public Health Prep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 Overexpression Triggers an IL1α Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance.
Shou Liu, Ji Shin Lee, Chunfa Jie, Min Ho Park, Yoichiro Iwakura, David Reisman

Cancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.
Ivan Pasic, Kit M Wong, Jonghun J Lee, Osvaldo Espin-Garcia, Yonathan Brhane, David Reisman

Mol Carcinog· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Mutation Pair L858M/L861Q Caused Resistance to Both First- and Third-Generation EGFR Inhibitors, but Was Found to Be Sensitive to the Combination of Lapatinib and Erbitux.
Harini Bejjanki, Rohit Bishnoi, David Reisman

J Thorac Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative treatment of patients with inoperable locally advanced, recurrent or metastatic head and neck squamous cell cancer, using a low-dose and personalized chemotherapeutic regimen.
Rohit Bishnoi, Jeffery Bennett, David N Reisman

Oncol Lett· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.
Geoffrey Liu, Sinead Cuffe, Shermi Liang, Abul Kalam Azad, Lu Cheng, David N Reisman

Clin Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome.
Grzegorz J Korpanty, Lawson Eng, Xin Qiu, Olusola Olusesan Faluyi, Daniel J Renouf, David Reisman

Oncotarget· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRM polymorphisms, pancreatic cancer risk and survival.
Maja Segedi, Laura N Anderson, Osvaldo Espin-Garcia, Ayelet Borgida, Teresa Bianco, David Reisman

Int J Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions .
Stefanie B Marquez-Vilendrer, Sudhir K Rai, Sarah Jb Gramling, Li Lu, David N Reisman

Oncoscience· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development.
Stefanie B Marquez-Vilendrer, Sudhir K Rai, Sarah Jb Gramling, Li Lu, David N Reisman

Oncoscience· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of BRG1 silencing in primary cancers.
Stefanie B Marquez-Vilendrer, Kenneth Thompson, Li Lu, David Reisman

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Base of tongue squamous cell carcinoma with infiltrative bone marrow carcinomatosis after definitive chemoradiation: A case report.
Kaitlin Christopherson, David N Reisman, Kristianna Fredenburg, Reordan DeJesus, William M Mendenhall

Head Neck· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition.
Huacheng Luo, Anitha K Shenoy, Xuehui Li, Yue Jin, Lihua Jin, David Reisman

Cell Rep· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth.
Yogin Patel, Nirav Shah, Ji Shin Lee, Eleni Markoutsa, Chunfa Jie, David Reisman

Oncotarget· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of functional Brm protein from Brm knockout mice.
Kenneth W Thompson, Stefanie B Marquez, Li Lu, David Reisman

Oncoscience· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
Shou Liu, Kideok Jin, Yvonne Hui, Jie Fu, Chunfa Jie, David Reisman

Cancer Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma.
Martin J Edelman, Josephine Feliciano, Binbin Yue, Pablo Bejarano, Olga Ioffe, David Reisman

Hum Pathol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1--letter.
Kenneth W Thompson, Stefanie B Marquez, David Reisman

Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors.
Bhaskar Kahali, Jinlong Yu, Stefanie B Marquez, Kenneth W Thompson, Shermi Y Liang, David Reisman

Oncotarget· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis